Skip to main contentSkip to search and navigation

UEF eREPOSITORY

    • English
    • suomi
  • English 
    • English
    • suomi
  • Login
View Item 
  •   Home
  • Artikkelit
  • Terveystieteiden tiedekunta
  • View Item
  •   Home
  • Artikkelit
  • Terveystieteiden tiedekunta
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Incidence and Prevalence of Antiepileptic Medication Use in Community-Dwelling Persons with and without Alzheimer's Disease

Thumbnail
Files
Article (461.5Kb)
Self archived version
published version
Date
2018
Author(s)
Sarycheva, Tatyana
Taipale, Heidi
Lavikainen, Piia
Tiihonen, Jari
Tanskanen, Antti
Hartikainen, Sirpa
Tolppanen, Anna-Maija
Unique identifier
10.3233/JAD-180594
Metadata
Show full item record
More information
Research Database SoleCris

Self-archived article

Citation
Sarycheva, Tatyana. Taipale, Heidi. Lavikainen, Piia. Tiihonen, Jari. Tanskanen, Antti. Hartikainen, Sirpa. Tolppanen, Anna-Maija. (2018). Incidence and Prevalence of Antiepileptic Medication Use in Community-Dwelling Persons with and without Alzheimer's Disease.  Journal of Alzheimer's Disease, 66 (1) , 387-395. 10.3233/JAD-180594.
Rights
© IOS Press and the authors
Licensed under
CC BY-NC http://creativecommons.org/licenses/by-nc/4.0/
Abstract

Background:
Although antiepileptic drugs (AEDs) have a potential for adverse drug reactions in older populations, little is known about their use in relation to Alzheimer’s disease (AD) diagnosis.

Objectives:
In this study, we investigated the incidence and prevalence of AED use in relation to AD diagnosis.

Methods:
The MEDALZ–study includes all Finnish persons who received clinically verified AD diagnoses (n = 70,718) during 2005–2011 and a matched comparison cohort without AD (n = 70,718). AD diagnoses were identified from the Special Reimbursement Register. We used the Prescription Register to identify dispensed AEDs. Incident AED users were identified with a one-year washout period 9-10 years before AD diagnosis, and incidence rates per 100 person-years were calculated for each six-month period from nine years before to five years after AD diagnosis. Prevalence was assessed as proportion using AEDs during each six-month time period for incident use.

Results:
Persons with AD were more likely to use AEDs during the study period (4.3%) than persons without AD (3.2%). The incidence and prevalence of AED use was higher among persons with AD and increased around the time of AD diagnosis. Epilepsy diagnoses did not explain these differences. Persons with AD were more likely to use older AEDs.

Conclusion:
Our study highlights the need to balance effective symptom control with the possible risks of treatment.

Subjects
Alzheimer’s disease   antiepileptic drugs   dementia   incidence   prevalence   
URI
https://erepo.uef.fi/handle/123456789/7098
Link to the original item
http://dx.doi.org/10.3233/JAD-180594
Publisher
IOS Press
Collections
  • Terveystieteiden tiedekunta [1337]
University of Eastern Finland
OpenAccess
eRepo
erepo@uef.fi
UEF Open Science
Accessibility in eRepo
Service provided by
the University of Eastern Finland Library
Library web pages
Twitter
Facebook
Youtube
Library blog
 sitemap
Search

Browse

All of the ArchiveResource types & CollectionsBy Issue DateAuthorsTitlesSubjectsFacultyDepartmentFull organizationSeriesMain subjectThis CollectionBy Issue DateAuthorsTitlesSubjectsFacultyDepartmentFull organizationSeriesMain subject

My Account

Login
University of Eastern Finland
OpenAccess
eRepo
erepo@uef.fi
UEF Open Science
Accessibility in eRepo
Service provided by
the University of Eastern Finland Library
Library web pages
Twitter
Facebook
Youtube
Library blog
 sitemap